Angela Hart of Kaiser Health News

As insulin-makers face long-standing complaints of price-gouging, California is diving into the prescription drug business, attempting to produce its own brand of generic insulin and sell it at below-market prices to people with diabetes.

Democratic lawmakers in California shied away from single-payer legislation that would have put state government in charge of health care and taxed Californians heavily to do so.